Received Jun 5, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Z011090 | — |
No other AE/No PQC.; Pharmacist calling with report of a product being administered after a temperature excursion. Date of excursion: 4/1/2026-4/22/2026 Administration: 4/22/2026 Name of vaccine(s): GARDASIL 9 Lot/Expiration: z011090 8/7/2027 Temperature/Time: (14.9c); This spontaneous report was received from a pharmacist and refers to a 22-year-old female patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not provided. On 22-Apr-2026, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) 0.5 mL once by health care professional as prophylaxis (route and anatomical site of administration was not provided; lot #Z011090 has been verified to be valid; expiration date reported and established as: 07-Aug-2027). The product was being administered after a temperature excursion (dated on 01-Apr-2026). With a Temperature/Time: 14.9c for 528 hours. No other adverse events (AE)/product quality complaint (PQC). Date of excursion: 4/1/2026-4/22/2026 Administration: 4/22/2026 Name of vaccine(s): GARDASIL 9 Lot/Expiration: z011090 8/7/2027 No previous AE cases: 03005796, 03005797, 03005801, 03005802, 03005803 No other AE/No PQC.